Biopreneur is planning it’s a long-waited Executive - Bio-business program for scientist, entrepreneurs, and pharmaceuticals

 executives. The workshop will be a weeklong intensive program containing following modules below. The program will be in partnership with local institutions, universities and the life-sciences industry. A team of experts will deliver the essence of their wisdom from their own experiences and fundamentals of business economics based on proven theories, street-wiseness and ethics.
 
Bio-business – a new Gold Rush:

Bio- business comprises over $10 trillion or 30 percent of global economic activity that globally.  Countries throughout the world have identified new opportunities in the bio-business arena as the next hot technology area and are investing in training their scientists, setting up state-of-the-art life science and technology knowledge clusters, and establish viable biotechnology industries to fuel growth in bio-business areas.
 
In the recent years, there are more willingness and push for cross-disciplinary work and ventures between high-tech and biotech. Professional and business investors may find biotech as a new Gold Rush of the time. Biotech offers infinite opportunities as long as human being resides in this planet.
 
It is coined that the bio-business is going to be the fastest growing sector in the world during this century. Some are even designated 21st century as the bio-century. This workshop designed to provide non-bio professionals a broader understanding of the of field and opportunities lies within. Can you afford be simple a spectator.
 
Paradigm of Bio-business:

The biotech business is witnessed in our everyday life from toothpaste to the medicine cabinet. It occupies more of our personal economics and social relationships from happiness to love than what we normally realize. With the recent convergence of IT and nanotech with biotechnology, the Bio-field is growing and enabling more economic opportunities to be captured.
 
As every discipline goes through its roller-coaster of highs and hypes, bio went through its own high and hype in the mid 80s, while the IT-dot.com had its share in the late 90s. During this coaster ride many fared well with the game while significant others lost a big chunk of their portfolio worth; however, the fundamentals remained the same and those who maneuvered with sound understanding of the field fared the best.
 
Common Senses not common traits:

Common sense of fundamental doctrines in most businesses is universal and applicable all of the time – either in a depressed or vibrant economy. What mainly differ are the business and the intrinsic model that follows the business. Know the specifics and understand the unique-nature of the field gives one the professional tools, skills and wit to win the race of apparent ambiguity. People fail in their endeavors not just because they do not know, but more because of confusion and lack of confidence arises from the weak understanding of the interlinking of the many ‘bio-parts’. Biotech, by virtue, has its own specific and unique distinction. Having spherical knowledge and understanding of the field would help one to make prudent decisions either for business investment or for career development in the field.